Qfin Holdings, Inc. (HKG:3660)

Market Cap	35.21B
Revenue (ttm)	18.98B
Net Income (ttm)	7.40B
Shares Out	n/a
EPS (ttm)	50.14
PE Ratio	4.76
Forward PE	4.50
Dividend	5.05 (3.87%)
Ex-Dividend Date	Apr 22, 2025

Volume	250
Average Volume	5,298
Open	130.80
Previous Close	130.80
Day's Range	130.80 - 131.60
52-Week Range	70.10 - 204.00
Beta	0.54
RSI	19.73
Earnings Date	Aug 22, 2025

About Revance Therapeutics

Qfin Holdings, Inc., together with its subsidiaries, operate AI- driven credit-tech platform under the Qifu Jietiao brand in the People’s Republic of China. The company provides credit-driven services that match borrowers with financial institutions to conduct borrower acquisition, credit assessment, fund matching, and post-facilitation services; and platform services, including loan facilitation and post-facilitation services to financial institution partners under an intelligence credit engine, referral services, and other technology solution...

• Industry: Credit Services
• Sector: Financials
• Founded: 2016
• Employees: 3,527
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 3660

Financial Performance

In 2024, Qfin Holdings's revenue was 17.17 billion, an increase of 5.38% compared to the previous year's 16.29 billion. Earnings were 6.26 billion, an increase of 46.18%.